The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| FSGEX | MRSKX | FSGEX / MRSKX | |
| Total Expense Ratio | 0.01 | 0.64 | 2% |
| Annual Report Gross Expense Ratio | 0.01 | 0.65 | 2% |
| Fund Existence | 17 years | 20 years | - |
| Gain YTD | 16.995 | 14.457 | 118% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | N/A | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 77B | 17.7B | 435% |
| Annual Yield % from dividends | 2.58 | 1.85 | 140% |
| Returns for 1 year | 27.39 | 17.29 | 158% |
| Returns for 3 years | 73.92 | 45.80 | 161% |
| Returns for 5 years | 55.60 | 28.11 | 198% |
| Returns for 10 years | 133.80 | 118.99 | 112% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IAXIX | 8.44 | N/A | N/A |
| VY® T. Rowe Price Divers Mid Cap Gr I | |||
| MVGMX | 18.76 | N/A | N/A |
| MFS Low Volatility Global Equity R4 | |||
| JMVRX | 36.54 | N/A | N/A |
| JPMorgan Mid Cap Value R5 | |||
| LYFCX | 18.40 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||
| TQCIX | 22.56 | N/A | N/A |
| Touchstone Dividend Equity Institutional | |||